Literature DB >> 15688019

Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells.

Lindsay C Spender1, Hannah J Whiteman, Claudio Elgueta Karstegl, Paul J Farrell.   

Abstract

RUNX transcription factors are important in development and in numerous types of human cancer. They act as either transcriptional activators or repressors and can be proto-oncogenes or tumour suppressors. Understanding their regulation and interaction may explain how RUNX factors contribute to such different and often opposing biological processes. We show that RUNX3 regulates RUNX1 expression, contributing to the mutually exclusive expression of RUNX3 and RUNX1 in human B lymphoid cell lines. RUNX3 repressed the RUNX1 P1 promoter by binding specifically to conserved RUNX sites near the transcription start of the promoter. siRNA inhibition of RUNX3 in lymphoblastoid cells resulted in increased RUNX1 expression, indicating that continuous expression of physiological levels of RUNX3 is required to maintain repression. Furthermore, expression of RUNX3 was required for efficient proliferation of B cells immortalized by Epstein-Barr virus. Cross-regulation between different RUNX family members is therefore a means of controlling RUNX protein expression and must now be considered in the interpretation of pathological changes due to loss of RUNX3 tumour suppressor function or following gene duplication or translocation events.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15688019     DOI: 10.1038/sj.onc.1208404

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

Review 1.  The RUNX complex: reaching beyond haematopoiesis into immunity.

Authors:  Dominic Chih-Cheng Voon; Yit Teng Hor; Yoshiaki Ito
Journal:  Immunology       Date:  2015-10-25       Impact factor: 7.397

2.  Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2.

Authors:  Walter Lucchesi; Gareth Brady; Oliver Dittrich-Breiholz; Michael Kracht; Rainer Russ; Paul J Farrell
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

3.  Super-enhancers for RUNX3 are required for cell proliferation in EBV-infected B cell lines.

Authors:  Hiroki Hosoi; Akiko Niibori-Nambu; Giselle Sek Suan Nah; Avinash Govind Bahirvani; Michelle Meng Huang Mok; Takaomi Sanda; Alan Prem Kumar; Daniel G Tenen; Yoshiaki Ito; Takashi Sonoki; Motomi Osato
Journal:  Gene       Date:  2021-01-12       Impact factor: 3.688

4.  A germline point mutation in Runx1 uncouples its role in definitive hematopoiesis from differentiation.

Authors:  Christopher R Dowdy; Dana Frederick; Sayyed K Zaidi; Jennifer L Colby; Jane B Lian; Andre J van Wijnen; Rachel M Gerstein; Janet L Stein; Gary S Stein
Journal:  Exp Hematol       Date:  2013-06-30       Impact factor: 3.084

5.  The role for runt related transcription factor 2 (RUNX2) as a transcriptional repressor in luteinizing granulosa cells.

Authors:  Eun-Sil Park; Jiyeon Park; Renny T Franceschi; Misung Jo
Journal:  Mol Cell Endocrinol       Date:  2012-06-17       Impact factor: 4.102

6.  Down-regulation of Runx1 expression by TCR signal involves an autoregulatory mechanism and contributes to IL-2 production.

Authors:  Won Fen Wong; Mineo Kurokawa; Masanobu Satake; Kazuyoshi Kohu
Journal:  J Biol Chem       Date:  2011-02-03       Impact factor: 5.157

Review 7.  Cell cycle and developmental control of hematopoiesis by Runx1.

Authors:  Alan D Friedman
Journal:  J Cell Physiol       Date:  2009-06       Impact factor: 6.384

Review 8.  The RUNX family in breast cancer: relationships with estrogen signaling.

Authors:  N-O Chimge; B Frenkel
Journal:  Oncogene       Date:  2012-10-08       Impact factor: 9.867

9.  Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation.

Authors:  Gareth Brady; Hannah J Whiteman; Lindsay C Spender; Paul J Farrell
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

10.  TGF-beta induces apoptosis in human B cells by transcriptional regulation of BIK and BCL-XL.

Authors:  L C Spender; D I O'Brien; D Simpson; D Dutt; C D Gregory; M J Allday; L J Clark; G J Inman
Journal:  Cell Death Differ       Date:  2009-01-09       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.